Health Care & Life Sciences » Pharmaceuticals | Sawai Pharmaceutical Co. Ltd.

Sawai Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
89,823
105,454
123,492
132,392
168,068
184,341
Cost of Goods Sold (COGS) incl. D&A
48,980
60,753
72,683
81,470
102,873
114,615
Gross Income
40,843
44,701
50,809
50,922
65,195
69,726
SG&A Expense
21,753
24,013
27,624
27,575
43,019
43,878
EBIT
19,090
20,688
23,185
-
22,176
25,848
Unusual Expense
-
-
157
-
-
-
Non Operating Income/Expense
40
136
135
305
849
175
Interest Expense
213
255
386
286
1,126
553
Pretax Income
18,989
20,297
23,091
22,757
20,251
25,666
Income Tax
6,797
6,244
5,936
4,788
6,140
5,939
Consolidated Net Income
12,192
14,053
17,155
17,969
14,111
19,727
Net Income
12,192
14,053
17,155
17,969
14,017
19,376
Net Income After Extraordinaries
12,192
14,053
17,155
17,969
14,017
19,376
Net Income Available to Common
12,192
14,053
17,155
17,969
14,017
19,376
EPS (Basic)
365.18
382.26
465.55
487.39
360.49
442.63
Basic Shares Outstanding
33
37
37
37
39
44
EPS (Diluted)
330.41
381.85
465.24
487.10
360.27
442.33
Diluted Shares Outstanding
37
37
37
37
39
44
EBITDA
24,079
26,551
30,229
31,867
36,415
42,128
Non-Operating Interest Income
72
-
-
1
51
196
Minority Interest Expense
-
-
-
-
94
351

About Sawai Pharmaceutical Co.

View Profile
Address
5-2-30 Miyahara
Osaka Osaka 532
Japan
Employees -
Website http://www.sawai.co.jp
Updated 07/08/2019
Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.